Screener
Eligibility screening
Phase 3 Extension Trial to Evaluate Long-Term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus
21 US sites in AL, CA, CO, FL +8
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.